Bank of Montreal Discloses $43.9M 3M Stake, $23.1M 10X Genomics Position

TL;DR

**BMO's Q4 2023 13F shows big bets on 3M and 10X Genomics.**

AI Summary

Bank of Montreal /CAN/ filed its 13F-HR on February 8, 2024, disclosing its equity holdings as of December 31, 2023. The filing reveals significant positions, including 401,000 shares of 10X Genomics Inc. CL A COM valued at $23,113,640, and 398,725 shares of 3M Co. COM valued at $43,903,610. This matters to investors because it provides transparency into a major financial institution's investment strategy, potentially signaling confidence or concern in specific sectors or companies, which can influence market sentiment and stock prices.

Why It Matters

This filing offers a glimpse into Bank of Montreal's investment strategy, which can influence market perception and potentially impact the stock prices of the disclosed holdings. Investors can use this information to align their portfolios or identify potential investment opportunities.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of past holdings and does not indicate any immediate financial risk to Bank of Montreal itself.

Analyst Insight

A smart investor would analyze the performance of 3M Co. and 10X Genomics Inc. since December 31, 2023, and consider if Bank of Montreal's disclosed positions align with their own investment thesis, potentially using this as a signal for further research into these specific companies or their respective sectors.

Key Numbers

• $43.9M — Value of 3M Co. COM holding (Represents a substantial investment by Bank of Montreal.)
• 398,725 SH — Shares of 3M Co. COM (Indicates the quantity of 3M stock held by Bank of Montreal.)
• $23.1M — Value of 10X Genomics Inc. CL A COM holding (Highlights another significant investment by Bank of Montreal.)
• 401,000 SH — Shares of 10X Genomics Inc. CL A COM (Shows the quantity of 10X Genomics stock held by Bank of Montreal.)
• 20231231 — Conformed Period of Report (Specifies the date the reported holdings were accurate.)

Key Players & Entities

• BANK OF MONTREAL /CAN/ (company) — filer of the 13F-HR
• Eric Moss (person) — SVP, DGC, Chief Compliance Officer
• 10X GENOMICS INC CL A COM (company) — a significant holding
• 3M CO COM (company) — a significant holding
• $23,113,640 (dollar_amount) — value of 10X Genomics Inc. holding
• $43,903,610 (dollar_amount) — value of 3M Co. holding
• December 31, 2023 (date) — period of report
• February 8, 2024 (date) — filing date

Forward-Looking Statements

• Bank of Montreal may continue to hold or increase its position in 3M Co. COM, indicating a long-term positive outlook on the company. (3M Co. COM) — medium confidence, target: Q1 2024
• The significant investment in 10X Genomics Inc. CL A COM suggests Bank of Montreal sees growth potential in the biotechnology sector. (10X Genomics Inc. CL A COM) — medium confidence, target: Q1 2024

FAQ

Filing Documents

• primary_doc.html (13F-HR)
• primary_doc.xml (13F-HR) — 5KB
• MajorUSBMO20231229.html (INFORMATION TABLE)
• MajorUSBMO20231229.xml (INFORMATION TABLE) — 5888KB
• 0000927971-24-000001.txt ( ) — 5893KB

From the Filing

SEC FORM 13F-HR The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE OMB APPROVAL OMB Number: 3235-0006 Estimated average burden hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 12-31-2023 Check here if Amendment    Amendment Number: This Amendment (Check only one.):    is a restatement.    adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BANK OF MONTREAL /CAN/ Address: 1 FIRST CANADIAN PLACE TORONTO , A6   M5X 1A1 Form 13F File Number: 028-07640 CRD Number (if applicable): The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Eric Moss Title: SVP, DGC, Chief Compliance Officer Phone: (416) 359-6226 Signature, Place, and Date of Signing: s// Eric Moss Toronto ,  A6 02-08-2024 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)    13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)    13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 8 Form 13F Information Table Entry Total: 11,901 Form 13F Information Table Value Total: 329,740,691,088 (round to nearest dollar) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] No. Name Form 13F File No. CRD No. (if applicable) SEC File No. (if applicable) CIK 1 Bank of Montreal Europe Plc 028-17461 2 BMO Asset Management Inc. 028-16018 3 BMO Bank N.A. 4 BMO CAPITAL MARKETS CORP. 028-17436 000016686 801-73047 5 BMO Family Office, LLC 028-17442 000110264 801-56868 6 BMO NESBITT BURNS INC. 028-16021 7 BMO PRIVATE INVESTMENT COUNSEL INC. 028-16020 000160344 801-74232 8 Stoker Ostler Wealth Advisors, Inc. 028-11481 000111320 801-54265

View Full Filing

View this 13F-HR filing on SEC EDGAR